{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:06:09Z","timestamp":1782457569674,"version":"3.54.5"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To report sex and age-specific<jats:italic>Chlamydia trachomatis<\/jats:italic>(Ct) seroprevalence estimates in the general population of the Netherlands between 1996 and 2017 and identify risk factors associated with Ct seropositivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Participants (n=5158, aged 15\u201359 years) were included from three independent nationwide population-based serosurveillance studies in 1996, 2007 and 2017. Participants completed a questionnaire on demographics and sexual behaviour. Serum antibodies were analysed using Medac Ct IgG ELISA test. Census weights were assigned to achieve seroprevalence estimates representative of the general Dutch population. Weighted seroprevalence estimates were stratified by gender, age and birth cohort. Trends and risk factors in men and women were identified using multivariable logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Weighted overall Ct seroprevalence was 10.5% (95% CI: 9.2% to 12.0%) in women and 5.8% (95% CI: 4.7% to 7.0%) in men. Among women &lt;25 years, there was a non-significant increase in seroprevalence from 5.9% (95% CI 3.7% to 9.2%) in 1996, to 7.6% (95% CI 5.1% to 11.1%) in 2007 and 8.8% (95% CI 5.5% to 13.9%) in 2017. Among women \u226525 years, the seroprevalence significantly decreased from 15.6% (95% CI: 12.2% to 19.7%) in 1996 to 9.5% (95% CI: 7.2% to 12.4%) in 2007 but did not further drop (11.2% (95% CI 8.1% to 15.3%) in 2017). In men, we did not observe trends between study rounds. In both men and women, having a non-Western migration background was a risk factor for seropositivity. In women, having had a prior sexually transmitted infection and \u22652 recent sex partners were risk factors for seropositivity as well.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We have not found evidence for a decrease in population seroprevalence in those under 25 years old despite decades of intensified testing-and-treatment efforts in the Netherlands. This suggests further monitoring of Ct burden in the general population is needed. If serum banks are used for this, specifically individuals &lt;25 years old and with diverse migration backgrounds should be included.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2023-055888","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T16:58:25Z","timestamp":1708102705000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Trends in<i>Chlamydia trachomatis<\/i>IgG seroprevalence in the general population of the Netherlands over 20 years"],"prefix":"10.1136","volume":"100","clinical-trial-number":[{"clinical-trial-number":"isrctn20164309","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8828-8904","authenticated-orcid":false,"given":"Zo\u00efe Willemijn","family":"Alexiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"van Aar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0146-6198","authenticated-orcid":false,"given":"Bernice Maria","family":"Hoenderboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servaas Antonie","family":"Morre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke Cornelia Maria","family":"Heijne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"2024021608483940000_100.1.31.1","doi-asserted-by":"crossref","unstructured":"Dukers-Muijrers NHTM , Evers YJ , Hoebe CJPA , et al . Controversies and evidence on Chlamydia testing and treatment in asymptomatic women and men who have sex with men: a narrative review. BMC Infect Dis 2022;22:255. doi:10.1186\/s12879-022-07171-2","DOI":"10.1186\/s12879-022-07171-2"},{"key":"2024021608483940000_100.1.31.2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2021-054992"},{"key":"2024021608483940000_100.1.31.3","doi-asserted-by":"crossref","unstructured":"Low N , Redmond S , Uusk\u00fcla A , et al . Screening for genital Chlamydia infection. Cochrane Database Syst Rev 2016;9:CD010866. doi:10.1002\/14651858.CD010866.pub2","DOI":"10.1002\/14651858.CD010866.pub2"},{"key":"2024021608483940000_100.1.31.4","doi-asserted-by":"crossref","unstructured":"Woodhall SC , Wills GS , Horner PJ , et al . Chlamydia trachomatis Pgp3 antibody population seroprevalence before and during an era of widespread opportunistic Chlamydia screening in England (1994-2012). PLoS One 2017;12:e0152810. doi:10.1371\/journal.pone.0152810","DOI":"10.1371\/journal.pone.0152810"},{"key":"2024021608483940000_100.1.31.5","doi-asserted-by":"crossref","unstructured":"Horner P , Soldan K , Vieira SM , et al . C. Trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010. PLoS One 2013;8:e72001. doi:10.1371\/journal.pone.0072001","DOI":"10.1371\/journal.pone.0072001"},{"key":"2024021608483940000_100.1.31.6","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.027409"},{"key":"2024021608483940000_100.1.31.7","unstructured":"van Wees D , Visser M , van Aar F , et al . Sexually transmitted infections in the Netherlands in 2021. National Institute for Public Health and the Environment (RIVM); 2022. Available: https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2022-0023.pdf [Accessed 1 Jul 2023]."},{"key":"2024021608483940000_100.1.31.8","unstructured":"Vriend HJ , Koedijk FDH , van den Broek IVF , et al . Sexually transmitted infections in the Netherlands in 2010. National Institute for Public Health and the Environment (RIVM); 2011. Available: https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/210261009.pdf [Accessed 1 Jul 2023]."},{"key":"2024021608483940000_100.1.31.9","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051074"},{"key":"2024021608483940000_100.1.31.10","doi-asserted-by":"crossref","unstructured":"Verberk JDM , Vos RA , Mollema L , et al . Third National Biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands. BMC Infect Dis 2019;19:470. doi:10.1186\/s12879-019-4019-y","DOI":"10.1186\/s12879-019-4019-y"},{"key":"2024021608483940000_100.1.31.11","first-page":"301","article-title":"Second National serum Bank for population-based seroprevalence studies in the Netherlands","volume":"67","author":"van der Klis","year":"2009","journal-title":"Neth J Med"},{"key":"2024021608483940000_100.1.31.12","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268898001587"},{"key":"2024021608483940000_100.1.31.13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg479"},{"key":"2024021608483940000_100.1.31.14","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.2.584-587.2002"},{"key":"2024021608483940000_100.1.31.15","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-0912-4"},{"key":"2024021608483940000_100.1.31.16","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050386"},{"key":"2024021608483940000_100.1.31.17","unstructured":"Lumley T . Survey: analysis of complex survey samples. R package version 4.2-1. 2020."},{"key":"2024021608483940000_100.1.31.18","doi-asserted-by":"crossref","unstructured":"Mindell JS , Giampaoli S , Goesswald A , et al . Sample selection, recruitment and participation rates in health examination surveys in Europe--experience from seven national surveys. BMC Med Res Methodol 2015;15:78. doi:10.1186\/s12874-015-0072-4","DOI":"10.1186\/s12874-015-0072-4"},{"key":"2024021608483940000_100.1.31.19","doi-asserted-by":"crossref","unstructured":"Postema AEAS , Ferreira JA , van der Klis F , et al . Investigating sources of non-response bias in a population-based seroprevalence study of vaccine- preventable diseases in the netherlands. In Review [Preprint]. doi:10.21203\/rs.3.rs-2093388\/v1","DOI":"10.21203\/rs.3.rs-2093388\/v1"},{"key":"2024021608483940000_100.1.31.20","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268899003234"},{"key":"2024021608483940000_100.1.31.21","doi-asserted-by":"crossref","unstructured":"Marques PX , Wand H , Nandy M , et al . Serum antibodies to surface proteins of Chlamydia Trachomatis as candidate biomarkers of disease: results from the Baltimore Chlamydia adolescent\/young adult reproductive management (CHARM) cohort. FEMS Microbes 2022;3:xtac004. doi:10.1093\/femsmc\/xtac004","DOI":"10.1093\/femsmc\/xtac004"},{"key":"2024021608483940000_100.1.31.22","doi-asserted-by":"crossref","unstructured":"Hoenderboom BM , van Willige ME , Land JA , et al . Antibody testing in estimating past exposure to CHlamydia Trachomatis in the Netherlands Chlamydia cohort study. Microorganisms 2019;7:442. doi:10.3390\/microorganisms7100442","DOI":"10.3390\/microorganisms7100442"},{"key":"2024021608483940000_100.1.31.23","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1093\/cid\/ciaa1879","article-title":"Seroprevalence of Chlamydia trachomatis among female adults in the United States: the national health and nutrition examination surveys","volume":"73","author":"Petersen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024021608483940000_100.1.31.24","doi-asserted-by":"crossref","unstructured":"Hulstein SH , Matser A , Alberts CJ , et al . Differences in Chlamydia Trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual Healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the healthy life in an urban setting (HELIUS) study. BMC Infect Dis 2018;18:612. doi:10.1186\/s12879-018-3533-7","DOI":"10.1186\/s12879-018-3533-7"},{"key":"2024021608483940000_100.1.31.25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis621"},{"key":"2024021608483940000_100.1.31.26","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2004.009415"},{"key":"2024021608483940000_100.1.31.27","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2018-053915"},{"key":"2024021608483940000_100.1.31.28","doi-asserted-by":"crossref","unstructured":"Blomquist PB , Mighelsen SJ , Wills G , et al . Sera selected from national STI surveillance system shows Chlamydia Trachomatis Pgp3 antibody correlates with time since infection and number of previous infections. PLoS One 2018;13:e0208652. doi:10.1371\/journal.pone.0208652","DOI":"10.1371\/journal.pone.0208652"},{"key":"2024021608483940000_100.1.31.29","doi-asserted-by":"crossref","unstructured":"Hufnagel K , Hoenderboom B , Harmel C , et al . Chlamydia Trachomatis whole-proteome microarray analysis of the Netherlands Chlamydia cohort study. Microorganisms 2019;7:703. doi:10.3390\/microorganisms7120703","DOI":"10.3390\/microorganisms7120703"},{"key":"2024021608483940000_100.1.31.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30159-2"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2023-055888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T16:58:34Z","timestamp":1708102714000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2023-055888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,17]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/sextrans-2023-055888"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2023-055888","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]}}}